Pfizer/BioNTech: Comirnaty

Vaccine Type: RNA

This vaccine may also be referred to as Tozinameran, BNT162b2

Vaccine Trial & Approval Tracker

This vaccine is approved.

About Trial Phases

Phase 1: 15 Trials

Phase 2: 46 Trials

Phase 3: 24 Trials

Registered Trials